tiprankstipranks
Advertisement
Advertisement
Cytokinetics Maintained at Buy on Competitive Validation and Differentiation; $99 Price Target Reaffirmed
PremiumRatingsCytokinetics Maintained at Buy on Competitive Validation and Differentiation; $99 Price Target Reaffirmed
23d ago
Analyst Reiterates Buy on Cytokinetics, Citing Aficamten’s Best-in-Class Profile and Safety Edge, Keeps $103 Price Target Unchanged
Premium
Ratings
Analyst Reiterates Buy on Cytokinetics, Citing Aficamten’s Best-in-Class Profile and Safety Edge, Keeps $103 Price Target Unchanged
23d ago
Cytokinetics: Competitive Overhang Eases After EDG-7500 Data, Analyst Reiterates Buy and $102 Price Target
Premium
Ratings
Cytokinetics: Competitive Overhang Eases After EDG-7500 Data, Analyst Reiterates Buy and $102 Price Target
23d ago
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
PremiumThe FlyStubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
2M ago
Cytokinetics initiated with a Buy, named a top pick at Citi
Premium
The Fly
Cytokinetics initiated with a Buy, named a top pick at Citi
2M ago
Cytokinetics price target raised to $97 from $92 at JPMorgan
Premium
The Fly
Cytokinetics price target raised to $97 from $92 at JPMorgan
2M ago
Cytokinetics 9.8M share Secondary priced at $71.00
PremiumThe FlyCytokinetics 9.8M share Secondary priced at $71.00
2M ago
Cytokinetics price target raised to $108 from $98 at Stifel
Premium
The Fly
Cytokinetics price target raised to $108 from $98 at Stifel
2M ago
Cytokinetics price target raised to $119 from $101 at RBC Capital
Premium
The Fly
Cytokinetics price target raised to $119 from $101 at RBC Capital
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100